OCS-01: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery (clinicaltrials.gov) - Jan 11, 2023 - P3 | N=240 | Recruiting | Sponsor: Oculis | Not yet recruiting ➔ Recruiting
Enrollment open • Surgery • Cataract • Immunology • Inflammation • Ocular Inflammation • Ophthalmology • Pain
|